Nijmegen, the Netherlands –  Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced that its algorithm for mitotic figure counting has achieved CE marking under the In Vitro Diagnostic...

BOSTON, MA / ACCESSWIRE / August 28, 2024 / PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that its AISightⓇ Dx Image Management System (IMS) is In Vitro Diagnostic Regulation...

Proscia: Regulatory milestone to accelerate company’s international growth amid expanding presence in Europe PHILADELPHIA–(BUSINESS WIRE)– Proscia, a leader in digital and computational pathology solutions, today...

Visiopharm, a world leader in AI-driven precision pathology software, today announced that its existing portfolio of diagnostic apps have all been certified under the new In Vitro Diagnostic Regulation (IVDR). The major difference between...